The latest vaccines are designed to target XBB.1.5, the dominant variant throughout much of 2023—until now.Read this story <a href="https://www.wired.com/story/covid-vaccine-boosters-2023-moderna-pfizer/">here</a>. 

Learn about your ad choices: <a href="https://dovetail.prx.org/ad-choices">dovetail.prx.org/ad-choices</a>

The latest vaccines are designed to target XBB.1.5, the dominant variant throughout much of 2023—until now. Read this story here. Learn about your ad choices: dovetail.prx.org/ad-choices

The latest vaccines are designed to target XBB.1.5, the dominant variant throughout much of 2023—until now.Read this story <a href="https://www.wired.com/story/covid-vaccine-boosters-2023-moderna-pfizer/" rel="noopener noreferrer">here</a>. 

Learn about your ad choices: <a href="https://dovetail.prx.org/ad-choices" rel="noopener noreferrer">dovetail.prx.org/ad-choices</a>

Covid Boosters Can’t Outpace New Mutations. Here’s Why They Still Work

Get in-depth coverage of current and future trends in technology, and how they are shaping business, entertainment, communications, science, politics, and society.

Science

Get in-depth coverage of current and future trends in technology, and how they are shaping business, entertainment, communications, science, politics, and society.

Share Covid Boosters Can’t Outpace New Mutations. Here’s Why They Still Work

Sign up to save your podcasts

Covid Boosters Can’t Outpace New Mutations. Here’s Why They Still Work

Covid Boosters Can’t Outpace New Mutations. Here’s Why They Still Work

More shows like Science, Spoken

This American Life

Freakonomics Radio

Dr Karl Podcast

What's New

Business, Spoken

Security, Spoken

Citadel Dropouts: a Game of Thrones Podcast